Cargando…
Exploration of residual disease in stem cell products from mantle cell lymphoma using next-generation sequencing
High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) has become a treatment option for fit patients with mantle cell lymphoma (MCL). However, these patients often relapse within few years, potentially caused by contaminating lymphoma cells within the reinfused stem cell pro...
Autores principales: | Elkjær, Lea Amalia Lind, Cédile, Oriane, Hansen, Marcus Høy, Nielsen, Christian, Møller, Michael Boe, Abildgaard, Niels, Haaber, Jacob, Nyvold, Charlotte Guldborg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9418493/ https://www.ncbi.nlm.nih.gov/pubmed/36039182 http://dx.doi.org/10.1016/j.lrr.2022.100341 |
Ejemplares similares
-
Detailed characterization of the transcriptome of single B cells in mantle cell lymphoma suggesting a potential use for SOX4
por: Valentin Hansen, Simone, et al.
Publicado: (2021) -
PB2394: PTPRJ AS A ROBUST DIFFERENTIATING MARKER IN MANTLE CELL LYMPHOMA
por: Valentin Hansen, Simone, et al.
Publicado: (2023) -
Distal chromosome 1q aberrations and initial response to ibrutinib in central nervous system relapsed mantle cell lymphoma
por: Hansen, Marcus Høy, et al.
Publicado: (2021) -
PB2386: ASSESSMENT OF NANOPORE LONG-READ WHOLE-GENOME SEQUENCING FOR THE DETECTION OF LARGE CHROMOSOMAL STRUCTURAL VARIANTS IN MANTLE CELL LYMPHOMA
por: Hansen, Marcus, et al.
Publicado: (2023) -
PB2158: EXPLORING THE BIOLOGICAL ROLE OF LILRA4 IN MANTLE CELL LYMPHOMA
por: Blum, M. K., et al.
Publicado: (2022)